Related Experiment Video
Updated: Jul 3, 2026
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Cell therapy for cardiac repair
1Cardiac Muscle Research Laboratory, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Insights
Cell regeneration therapies offer a promising new avenue for treating heart failure by replacing lost cardiomyocytes. Research explores various stem and progenitor cells for cardiac repair, with early clinical trials showing potential.
Area of Science:
- Regenerative Medicine
- Cardiovascular Biology
- Stem Cell Therapy
Background:
- Cardiovascular diseases, particularly congestive heart failure, represent a major cause of death and disability.
- Current treatments improve patient quality of life but do not address the critical loss of functional cardiomyocytes.
- The need for therapies that can regenerate heart tissue is significant.
Purpose of the Study:
- To review current findings on stem and progenitor cells for cardiac regeneration.
- To examine the potential of various cell types in repairing heart damage.
- To discuss recent therapeutic outcomes from preliminary clinical trials.
Main Methods:
- Review of experimental studies on embryonic and adult-derived stem/progenitor cells.
- Analysis of research on resident cardiac progenitor cells.
- Examination of data from early-phase clinical trials involving cell-based cardiovascular repair.
Main Results:
- Identification of resident cardiac progenitor cells has accelerated research in cardiac regeneration.
- Various stem and progenitor cell types are being investigated for their regenerative capabilities.
- Preliminary clinical trials are exploring the therapeutic efficacy of these cells in cardiovascular repair.
Conclusions:
- Cell regeneration therapies, utilizing stem and progenitor cells, present a potential paradigm shift in treating heart failure.
- Further research and clinical trials are essential to validate the safety and efficacy of these regenerative approaches.
- The field of cardiac regenerative biology is rapidly advancing, offering hope for improved patient outcomes.
Abstract:
Cardiovascular diseases remain the leading cause of morbidity and mortality in Western society. Among these diseases, congestive heart failure continues to be a significant health care burden. Recent medical and surgical advances in therapy have improved the quality and quantity of life for patients with heart failure. However, none of these therapies address the fundamental problem of loss of functional cardiomyocytes. Cell regeneration therapies have become an exciting potential treatment for heart failure and other cardiovascular diseases. This emerging therapeutic field has been pursued experimentally with both embryonic-derived stem cells and adult-derived progenitor cells. The identification of resident cardiac progenitor cells has propelled the field of cardiac regenerative biology forward at astonishing rates. This review will examine current findings of various stem and progenitor cells that have been proposed as potential sources for cardiac regeneration, and the recent therapeutic findings from preliminary clinical trials using some of these cell types for cardiovascular repair.
